Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30068863HIVENSG00000104365.16protein_codingIKBKBNoNo3551O14920
TVIS30068864HIVENSG00000104365.16protein_codingIKBKBNoNo3551O14920
TVIS30068865HIVENSG00000104365.16protein_codingIKBKBNoNo3551O14920
TVIS20000889HPVENSG00000104365.16protein_codingIKBKBNoNo3551O14920
TVIS20024504HPVENSG00000104365.16protein_codingIKBKBNoNo3551O14920
TVIS20066292HPVENSG00000104365.16protein_codingIKBKBNoNo3551O14920
TVIS20020491HPVENSG00000104365.16protein_codingIKBKBNoNo3551O14920
TVIS44022865HTLV-1ENSG00000104365.16protein_codingIKBKBNoNo3551O14920
TCGA Plot Options
Drug Information
GeneIKBKB
DrugBank IDDB00995
Drug NameAuranofin
Target IDBE0001154
UniProt IDO14920
Regulation Typeinhibitor
PubMed IDs12754408; 17034761
CitationsJeon KI, Byun MS, Jue DM: Gold compound auranofin inhibits IkappaB kinase (IKK) by modifying Cys-179 of IKKbeta subunit. Exp Mol Med. 2003 Apr 30;35(2):61-6.@@Youn HS, Lee JY, Saitoh SI, Miyake K, Hwang DH: Auranofin, as an anti-rheumatic gold compound, suppresses LPS-induced homodimerization of TLR4. Biochem Biophys Res Commun. 2006 Dec 1;350(4):866-71. Epub 2006 Sep 28.
GroupsApproved; Investigational
Direct ClassificationTetracarboxylic acids and derivatives
SMILESCCP(CC)(CC)=[Au]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O
Pathways
PharmGKBPA448510
ChEMBLCHEMBL1366